Literature DB >> 418906

[Preparation and experimental antitumor activity of a new semi-synthetic antibiotic: 14-diethoxyacetoxy daunorubicin (R.P. 33 921)].

R Maral, J B Ducep, D Farge, G Ponsinet, D Reisdorf.   

Abstract

14-diethoxyacetoxy daunorubicin (R.P. 33 921) was chosen among a series of new daunorubicin analogues. Its preparation from daunorubicin and its biological activities are described. It displays an antitumoral activity in mice with a better chemotherapeutic index than daunorubicin and doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418906

Source DB:  PubMed          Journal:  C R Acad Hebd Seances Acad Sci D


  3 in total

Review 1.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

2.  Comparative toxicity of detorubicin and doxorubicin, free and DNA-bound, for hemopoietic stem cells.

Authors:  M Huybrechts; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.

Authors:  G Mathé; M Bayssas; J Gouveia; D Dantchev; P Ribaud; D Machover; J L Misset; L Schwarzenberg; C Jasmin; M Hayat
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.